Why the study?
Although the association of type 2 diabetes with CVD is well described, the mechanisms, risk stratification, and screening strategies of CVD in type 1 diabetes are less understood.
Design
Review
Authors
Loading...
Supports avoiding routine CAD screening in asymptomatic T1D; leaves open prospective validation of T1D-specific risk tools.
This review highlights that while routine CAD screening in asymptomatic T1D patients is not recommended, emerging T1D-specific risk prediction tools are crucial for identifying high-risk individuals for targeted risk factor modification.
Sharma et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: